INKA1
Basic information
Region (hg38): 3:49803261-49805030
Previous symbols: [ "C3orf54", "FAM212A" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the INKA1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 20 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 20 | 3 | 0 |
Variants in INKA1
This is a list of pathogenic ClinVar variants found in the INKA1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-49804184-T-G | not specified | Uncertain significance (May 31, 2022) | ||
3-49804291-G-C | not specified | Uncertain significance (Apr 15, 2024) | ||
3-49804334-G-A | not specified | Uncertain significance (Nov 26, 2024) | ||
3-49804356-A-G | not specified | Likely benign (Dec 14, 2021) | ||
3-49804367-G-T | not specified | Uncertain significance (Jan 01, 2025) | ||
3-49804376-G-A | not specified | Uncertain significance (Feb 17, 2024) | ||
3-49804379-G-T | not specified | Uncertain significance (May 28, 2024) | ||
3-49804442-C-G | not specified | Uncertain significance (Feb 06, 2024) | ||
3-49804443-G-T | not specified | Uncertain significance (Mar 28, 2024) | ||
3-49804470-G-A | not specified | Likely benign (Feb 21, 2024) | ||
3-49804506-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
3-49804538-A-G | not specified | Likely benign (Nov 18, 2022) | ||
3-49804556-G-A | not specified | Uncertain significance (Feb 07, 2025) | ||
3-49804571-C-A | not specified | Uncertain significance (Feb 05, 2025) | ||
3-49804577-C-T | not specified | Uncertain significance (Mar 24, 2023) | ||
3-49804670-C-T | not specified | Uncertain significance (Sep 30, 2024) | ||
3-49804711-G-C | not specified | Uncertain significance (Aug 05, 2024) | ||
3-49804760-G-A | not specified | Uncertain significance (Jan 08, 2024) | ||
3-49804784-C-T | not specified | Uncertain significance (Feb 22, 2025) | ||
3-49804824-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
3-49804826-C-T | not specified | Uncertain significance (Apr 05, 2024) | ||
3-49804848-G-A | not specified | Uncertain significance (Dec 04, 2024) | ||
3-49804919-C-T | not specified | Uncertain significance (Mar 26, 2024) | ||
3-49804934-A-G | not specified | Uncertain significance (Jul 16, 2024) | ||
3-49804943-C-T | not specified | Uncertain significance (Feb 26, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
INKA1 | protein_coding | protein_coding | ENST00000333323 | 2 | 1777 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000614 | 0.741 | 125603 | 0 | 134 | 125737 | 0.000533 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.799 | 143 | 173 | 0.829 | 0.0000114 | 1822 |
Missense in Polyphen | 53 | 69.361 | 0.76411 | 705 | ||
Synonymous | 0.619 | 57 | 63.3 | 0.901 | 0.00000324 | 624 |
Loss of Function | 0.936 | 6 | 9.03 | 0.664 | 4.76e-7 | 99 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00519 | 0.00517 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00179 | 0.00180 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000711 | 0.0000703 |
Middle Eastern | 0.00179 | 0.00180 |
South Asian | 0.000229 | 0.000229 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Inhibitor of the serine/threonine-protein kinase PAK4 (PubMed:26607847). Acts by binding PAK4 in a substrate-like manner, inhibiting the protein kinase activity (PubMed:26607847). {ECO:0000269|PubMed:26607847}.;
Intolerance Scores
- loftool
- rvis_EVS
- 0.13
- rvis_percentile_EVS
- 63.2
Haploinsufficiency Scores
- pHI
- 0.124
- hipred
- N
- hipred_score
- 0.208
- ghis
- 0.519
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Inka1
- Phenotype
- reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- inka1a
- Affected structure
- neurocranium
- Phenotype tag
- abnormal
- Phenotype quality
- decreased size
Gene ontology
- Biological process
- neural tube development;negative regulation of protein serine/threonine kinase activity
- Cellular component
- nucleus;cytoplasm
- Molecular function
- protein binding;protein kinase binding;protein serine/threonine kinase inhibitor activity